Mass. Federal Judge Certifies Celexa, Lexapro Marketing Class Action

BOSTON — A Massachusetts federal judge has certified a class action brought by two Missouri residents who accuse the makers of Celexa and Lexapro of misrepresenting and concealing information concerning the effectiveness of the drugs for the treatment of depression in pediatric patients.

On Jan. 10, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts found that the “informed choice” allegations made by Ruth Dunham and Tanya Shippy is a “novel” theory, but viable under the Missouri Merchandising Practices Act.

The five plaintiffs in this action purchased Celexa or Lexapro for use by their minor …